Brief: Theraclion Says Strong Commercial Progress In The First Half Of 2018

Theraclion SA

16/07/2018 17:20

July 16 (Reuters) - Theraclion SA  ALTHER.PA :
    * THERACLION: STRONG COMMERCIAL PROGRESS IN THE FIRST HALF
OF 2018
    * H1 EUR 0.9M SALES: + 15% VS1H'17
    * LOOKING FOR 4 MILLION EUR FUNDING IN NEXT 6 MONTHS
    * SALES TO NON-GROUP CUSTOMERS UP 61%
    * H1 DOUBLING OF RECURRING REVENUES(1): + 87% VS1H'17
    * AT JUNE 30, 2018, THERACLION'S AVAILABLE CASH POSITION
AMOUNTED
TO EUR 1.5 MILLION
    * SAYS INTERMEDIATE RESULTS ARE IN LINE WITH OUR
EXPECTATIONS
    * SALE OF CONSUMABLES IS UP 54% IN LINE WITH INCREASE IN
NUMBER OF
TREATMENTS IN CLINICAL ROUTINE OF 68%
    * TOTAL NUMBER OF TREATMENTS INCREASED BY 89% IN FIRST HALF
    * SAYS PLAN FOR CE MARKING AND FDA SUBMISSION WILL SOON BE
DISCLOSED
    * IS CURRENTLY STUDYING SEVERAL FINANCING OPTIONS IN SECOND
HALF
OF 2018 AMOUNTING TO ABOUT EUR 4 MILLION
    * CARRIED OUT REVIEW OF ITS LIQUIDITY RISK AND IMPLEMENTED
ACTIONS
TO ENSURE GOING CONCERN UNTIL 30 JUNE 2019
    * SAYS TREATMENT OF VARICOSE VEINS BY ECHOTHERAPY REPRESENTS
A
GIGANTIC MARKET QUICKLY ACCESSIBLE
    * IT IS CURRENTLY STUDYING SEVERAL FINANCING OPTIONS IN
SECOND
HALF OF 2018 AMOUNTING TO ABOUT EUR 4 MILLION
    * JUST RECEIVED APPROBATION FOR EUR 1.7 MILLION FINANCING
OVER 3
YEARS FROM EUROSTAR TO FUND A PROJECT AIMED AT DEVELOPING FIRST
MARKETABLE HIFU MACHINE FOR TREATMENT OF CANCER

Source text for Eikon:  ID:nBw9xkGGPa 
Further company coverage:  ALTHER.PA 

 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))